Authors


Dana Wittenberg, MA

Latest:

Novel Methods to Predict Outcome Using Neuroimaging

The capacity of cognitive neuroscience to inform clinical practice has stimulated both excitement and controversy.


Daniel A. Rossignol, MD

Latest:

Environmental Toxicants and Autism Spectrum Disorder

On the association between symptoms of autism spectrum disorder with environmental toxin exposure.


Daniel B. Block, MD

Latest:

Sex, DSM-5- and the Apocalypse: A Commentary

I just finished reading Dr Zucker’s retort to Dr Frances’ critique of proposed categories for paraphilias in DSM5, as well as Dr Frances’ reply.


Daniel Bober, DO

Latest:

Understanding Anxiety Disorders in Children and Adolescents: Brief Overview and Update

Anxiety disorders are the most common mental conditions in the general population, including in children and adolescents. Young people can present with a pattern of anxiety symptoms somewhat different from that typically seen in adults. One of the most common aspects of this difference is that children (especially younger ones) may not report overt worries or fears, but instead manifest pronounced physical symptoms.


Daniel C. Javitt, MD, PhD

Latest:

Mini Quiz: Glutamate and Schizophrenia

The glutamate model of schizophrenia proposes that dysfunction will involve which brain regions?


Daniel C. Mathews, MD

Latest:

New Drug Developments for Bipolar Mania

While challenges in treating mania persist, the future discovery of novel therapeutic agents will likely expand our understanding of this devastating illness and provide key insights into future drug development.


Daniel Carlat, MD

Latest:

A Response by Daniel Carlat

From my standpoint as the author of Unhinged, Dr Haldipur’s review is both good news and bad news.


Daniel Castellanos, MD

Latest:

“Designer Drug” Use and Abuse: Implications for Psychiatrists

Psychiatrists are urged to familiarize themselves with these new drugs and the typical presentations of patients who use them since implications of misdiagnosis can be far-reaching.


Daniel E. Casey, MD

Latest:

Bipolar Disorder: Diagnostic Challenges and Treatment Strategies

The past few years have seen substantial progress in recognizing and treating several of the subtypes of bipolar disorder. This Special Report addresses the diagnostic challenges and the different strategies for managing these subtypes.


Daniel Essin, MA, MD

Latest:

Confusion about EHRs - It's Only Natural

There are a couple of facets of human nature that have a big impact on how people perceive EHRs and what they do, or don't do, with them.


Daniel F. Connor, MD

Latest:

Problems of Overdiagnosis and Overprescribing in ADHD

Doubt and confusion as to where ADHD fits into the general spectrum of illness further feeds the general perception that ADHD is a socially constructed disorder rather than a valid neurobiological disorder


Daniel Freeman, PhD

Latest:

Cognitive-Behavioral Therapy for Psychotic Disorders

The first generation of cognitive-behavioral therapy for psychosis, when added to standard care, has demonstrated efficacy in treating patients with delusions and hallucinations. Details in this article.


Daniel Gih, MD

Latest:

Confounding Factors in Treatment-Resistant Depression (Part 2): Comorbidities and Treatment Resistance

The role of subtyping and bipolarity in TRD was discussed in Part 1 of this 2-part article. Here we review a number of the most common confounding factors of TRD but limit our scope to comorbidities that can be directly addressed and treated by psychiatrists.



Daniel Le Grange, PhD

Latest:

The Treatment of Adolescent Eating Disorders

Notwithstanding sparse treatment data, recent efforts are beginning to provide clinicians with some clear treatment guidelines for medically unstable adolescents with anorexia nervosa.


Daniel M. Blumberger, MD, MSc

Latest:

The Current Status of Transcranial Direct Current Stimulation as a Treatment for Depression

Evidence has accumulated on the efficacy of transcranial direct current stimulation in major depression. The authors review its potential mechanism of action, findings from recent clinical trials, and potential role in the treatment of depressive disorders.


Daniel M. Blumberger, MD, MSc, FRCPC

Latest:

Transcranial Magnetic Stimulation in Neuropsychiatry: An Update

The potential of TMS as a treatment for cognitive disorders, fatigue, pain, and other manifestations of brain disease is discussed, as is the encouraging prospect for neuropsychiatric management of many patients.


Daniel Moldavsky, MD

Latest:

Transcultural Psychiatry for Clinical Practice

What are some of the pitfalls of treating patients from varying cultural backgrounds, what cultural issues should psychiatrists be aware of and how can they fit varying culturally based psychiatric disorders into a proper diagnostic framework? Using case studies, Dr. Moldavsky explores the clinical implications of culture in psychiatric practice.


Daniel Pistone, MD

Latest:

Are the Media and the Public Still Missing the Clues?

It is our responsibility as psychiatrists to educate the media and the public in general.


Daniel S. Schechter, MD

Latest:

Consequences of Social Mitigation Strategies

Researchers found a significant drop in life expectancy from depression, alcohol dependence, suicidality, increased divorce rates, and childhood trauma that are a direct result of social distancing.


Daniel T. Willliams, MD

Latest:

Psychiatric Diagnosis and Treatment of Somatizing Neuropsychiatric Disorders

Although the somatizing disorders cover a vast array of symptomatic domains across many medical specialties, this article addresses the broad topic conceptually.


Daniel W. Knoedler, MD

Latest:

Telepsychiatry Is a Team Sport

To run an effective telepsychiatry practice, a solid partnership between skilled personal on-site with patients and the psychiatrist on the other end of the call is a must.


Daniel W. Shuman, JD

Latest:

Tarasoff Redux

Notwithstanding the personal implications and its centrality to mental health professionals, in my 30 years of teaching and writing about the intersection of psychiatry and law, I had managed to avoid that rite of passage. I was not comfortable and found it difficult to say something original on a topic that has been so extensively explored.


Daniela Gitlin, MD

Latest:

There’s No Place Like Gnome

Being an outpatient psychiatrist is a lot like being married. Things go along, the same-old, for long periods. But then there's a moment. Today, with Leslie, I remember why I love my work.


Danielle Barry, PhD

Latest:

Obesity and Psychiatric Disorders

Obesity has emerged as a significant threat to public health throughout the developed world. The World Health Organization defines overweight as a body mass index of 25.0 to 29.9 kg/m2 and obesity as a BMI of 30.0 kg/m2 or greater.1 Nearly two-thirds of Americans are overweight or obese according to these criteria.2 Numerous health problems, including diabetes, cardiovascular disease, arthritis, and cancer, are associated with obesity. In addition, overweight and obese persons are more likely than their normal-weight peers to have a variety of psychiatric disorders.


Danny Wedding, PhD, MPH

Latest:

Making Psychotherapy Work: Collaborating Effectively With Your Patient

Making Psychotherapy Work: Collaborating Effectively with Your Patient is an engaging book that will interest most practicing psychotherapists.


Daphne Simeon, MD

Latest:

Emotional Maltreatment of Children: Relationship to Psychopathology

Emotional maltreatment is of two major types: emotional abuse and emotional neglect. While emotional abuse is easier to identify, emotional neglect is subtler, possibly more damaging, and poses even more challenging barriers to definition and study.


Darin D. Signorelli, MD

Latest:

Informed Consent and Civil Commitment in Emergency Psychiatry

Medical school graduation usually involves taking the Hippocratic oath, in which physicians vow not to intentionally harm their patients. Keeping patients safe is another basic principle of patient care. Physicians are charged with ensuring that their patients are in a safe environment and minimizing risks to their patients by carefully selecting treatment options.


Darin Dougherty, MD

Latest:

Advances in Neuroimaging: Impact on Psychiatric Practice

Neuroimaging is often used in clinical psychiatry to rule out medical and neurological conditions that can mimic psychiatric disease rather than for the diagnosis of specific psychiatric disorders.


Darrel A. Regier, MD, MPH

Latest:

Setting the Record Straight: A Response to Frances Commentary on DSM-V

The commentary “A Warning Sign on the Road to DSM-5: Beware of its Unintended Consequences” by Allen Frances, M.D., submitted to Psychiatric Times contains factual errors and assumptions about the development of DSM-V that cannot go unchallenged. Frances now joins a group of individuals, many involved in development of previous editions of DSM, including Dr. Robert Spitzer, who repeat the same accusations about DSM-V with disregard for the facts.

© 2024 MJH Life Sciences

All rights reserved.